Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Indian Indices Trade in Red; Energy Stocks Drag
Thu, 1 Jun 01:30 pm

After opening the day on a flat note, share markets in India witnessed volatile trading activity and are currently trading below the dotted line. Sectoral indices are trading on a mixed note with stocks in the pharma sector and stocks in the FMCG gas sector trading in green, while stocks in the oil and gas sector are leading the losses.

The BSE Sensex is trading down by 40 points (down 0.1%), and the NSE Nifty is trading down by 20 points (down 0.2%). Meanwhile, the BSE Mid Cap index is trading up by 0.4%, while the BSE Small Cap index is trading up by 0.7% The rupee is trading at 64.46 to the US$.

In news from India's manufacturing sector. The manufacturing sector stayed in expansion mode in May, charting a rebound notebandi induced downturn.

Indian manufacturing activity expanded for a fourth consecutive month in April, however at a slower pace. Manufacturing sector growth in the country moderated to a three-month low in May amid softer rise in new orders and, according to the Nikkei Purchasing Managers' Index (PMI) survey by Markit.

The PMI is the reading of the country's manufacturing sector output and is updated monthly. A reading above 50 indicates expansion, while any score below the mark denotes contraction.

Having deteriorated in December for the first time in one year, the health of India's manufacturing economy showed signs of improvement in January 2017.

The manufacturing PMI has charted its recovery from 49.6 in December 2016, to 52.5 in March, registering the fastest upward move since October 2016. At 52.5 in April, the PMI remained unchanged from the previous month. In May however, PMI growth slowed down to 51.7, still signifying expansion, albeit at a slower pace.

PMI Falls to 3 Month Low

It is evident from the above chart that the manufacturing activity is inching towards the pre-demonetisation levels noted in October 2016. However, manufacturing is seen to steadily pick up from the notebandi blues.

During May, there was "softer expansion" in both new orders and production. Incoming new work rose at the weakest pace since February, with slowdowns evident in the consumer and intermediate goods categories, while capital goods producers recorded a contraction in order books.

The survey added that below par manufacturing growth, and muted inflation could prompt the RBI to move towards an accommodative stance to support growth in the economy.

Just Released: Multibagger Stocks Guide
(2017 Edition)

In this report, we reveal four proven strategies to picking multibagger stocks.

Well over a million copies of this report have already been claimed over the years.

Go ahead, grab your copy today. It's Free.

NO-SPAM PLEDGE - We will NEVER rent, sell, or give away your e-mail address to anyone for any reason. You can unsubscribe from The 5 Minute WrapUp with a few clicks. Please read our Privacy Policy & Terms Of Use.

Looking ahead, production volumes are likely to rise further as businesses will seek to replenish their stocks, and look for acquisitions as remonetisation nears completion.

Moving on to news from stocks in the pharma sector. Sun Pharma share price is in focus today and surged over 2.5% in intraday trade.

The US arm of domestic drug major said that it is recalling over 13,200 bottles of antihistamine, Children's Cetirizine Hydrochloride chewable tablets, from the American market for failed specifications.

The drug was manufactured in the company's Halol plant, which is facing regulatory issues.

The US Food and Drug Administration (USFDA) said in a report that the ongoing class III recall is nationwide in the USA and Puerto Rico. As per the US health regulator, a class III recall is initiated in a situation, "in which use of or exposure to a violative product is not likely to cause adverse health consequences".

The reason for the recall as stated in USFDA's Enforcement Report is failed tablet/capsule specifications: out of specification results for increased tablet hardness.

Sun Pharma share price had plunged by over 25% in the last month over tepid results and subdued growth.

The BSE Healthcare Index too, is down by over 9% in the month gone by.

The Indian pharmaceutical industry has come under a lot of regulatory pressure in the past few years.

The sector has faced great volatility over the years.

We had written about the current predicament of Indian pharma companies in one of the premium editions of the 5 Minute WrapUp:

  • Over the past few years, risk in the US markets has increased. The US Food and Drug Administration has become stricter on products entering US borders. Surprise inspections have increased and companies are being issued warning letters. This has impacted the business and earnings of Indian pharma players, causing major volatility for the sector.

In such a volatile environment, how can earn good returns from the stock markets?

We believe a few super investors could provide the clue. These are the guys who've beaten the markets black and blue and have an eye for multi bagger stocks irrespective of the macro environment.

With respect to which super investors to follow, our Research analysts Kunal and Rohan have could be of great help courtesy their project, The Super Investors of India.

To know more about these super investors and their stock picking approach, download a free copy of - The Super Investors Of India.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Indian Indices Trade in Red; Energy Stocks Drag". Click here!


Views on News

Beware the Ides of March (Fast Profits Daily)

Mar 1, 2021

The month of March is usually difficult for traders. This time it will be even more so. Find out why in this video.

UTI Nifty200 Momentum 30 Index Fund: Aims to Benefit from Momentum Investing Strategy (Outside View)

Mar 1, 2021

PersonalFN analyses the features of UTI Nifty200 Momentum 30 Index Fund and explains the potential this fund has to offer to its investors.

How to Have a Perfectly Normal Day Even if Sensex Falls 2,000 Points (Profit Hunter)

Mar 1, 2021

How can someone witness a 2,000 point decline on the Sensex and still stay perfectly calm.

ITI Mid-Cap Fund: Investing in Potential Midcap Companies for Growth (Outside View)

Feb 26, 2021

PersonalFN analyses the features of ITI Mid-Cap Fund and explains the potential this fund has to offer to its investors.

NSE Glitch: Why Did the Market Go Up? (Fast Profits Daily)

Feb 26, 2021

In today's video, I'll discuss why thew stock market went up on Wednesday, 24 February 2021, when the NSE had to shut trading due to a technical glitch.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.


India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms


Mar 1, 2021 03:36 PM